# Fundación Santa Fe de Bogota: Observational study in Breast Neoplasms, Triple Negative Breast Neoplasms (370 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Fundación Santa Fe de Bogota |
| Sponsor type | Academic and hospital |
| Study | Clinical and Therapeutic Outcomes by Molecular Subtype in Breast Cancer |
| NCT ID | NCT07856225 |
| Phase | Observational |
| Status | recruiting |
| Conditions | Breast Neoplasms; Triple Negative Breast Neoplasms; HER2-Positive Breast Cancer; Hormone Receptor-Positive Breast Cancer |
| Intervention types | drug, other |
| Target enrollment | 370 |
| Site countries | Colombia |
| Posted | 2026-10-02 |
| Planned start | 2025-12-01 |
| Event | Newly registered study |
| Event date | 2026-10-02 |

## Why this score
- 370 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07856225). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.